6-(2-Chlorophenyl)-2-(morpholin-4-yl)-4-(trifluoromethyl)pyridine-3-carbonitrile

Catalog No. :
ACKYQA737
CAS No. :
478049-43-3
Molecular Formula :
C17H13ClF3N3O
Molecular Weight :
367.76

IUPAC Name:6-(2-chlorophenyl)-2-morpholino-4-(trifluoromethyl)nicotinonitrile

6-(2-Chlorophenyl)-2-(morpholin-4-yl)-4-(trifluoromethyl)pyridine-3-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$563.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(2-Chlorophenyl)-2-(morpholin-4-yl)-4-(trifluoromethyl)pyridine-3-carbonitrile
IUPAC Name6-(2-chlorophenyl)-2-morpholino-4-(trifluoromethyl)nicotinonitrile
MDL No.MFCD01814475
Molecular FormulaC17H13ClF3N3O
Molecular Weight367.76
SMILESN#CC1=C(C(F)(F)F)C=C(C2=CC=CC=C2Cl)N=C1N3CCOCC3
InChI KeyWYSSWELDYMNWDK-UHFFFAOYSA-N
Synonym6-(2-CHLOROPHENYL)-2-MORPHOLINO-4-(TRIFLUOROMETHYL)NICOTINONITRILE;3-Pyridinecarbonitrile, 6-(2-chlorophenyl)-2-(4-morpholinyl)-4-(trifluoromethyl)-
CAS No.478049-43-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACKYQA737 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKYQA737 route product structure diagram
    ACKYQA737478049-43-3
Inquiry

2. ACKYQA737 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNVCU612 route compound structure diagram
    ACNVCU6123900-89-8 In Stock
  4. Then
  5. ACKYQA737 route product structure diagram
    ACKYQA737478049-43-3
Inquiry

Comments (0)